FY2026 Earnings Forecast for ATNM Issued By HC Wainwright
Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Free Report) – Equities research analysts at HC Wainwright reduced their FY2026 EPS estimates for shares of Actinium Pharmaceuticals in a research report issued on Monday, April 28th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings of ($0.91) per share for the year, down from […]
